Similar articles

• Alteplase as an alternative to urokinase. Advisory Panel on Catheter-Directed Thrombolytic Therapy.

  Semba CP, Bakal CW, Calis KA, Grubbs GE, Hunter DW, Matalon TA, Murphy TP, Stump DC, Thomas S, Warner DL. Semba CP, et al. J Vasc Interv Radiol. 2000 Mar;11(3):279-87. doi: 10.1016/s1051-0443(07)61418-3. J Vasc Interv Radiol. 2000. PMID: 10735420 Review. No abstract available.
• [Acute portal vein thrombosis treated with locoregional fibrinolysis: a case report].

  Morelli Coppola G, Niola R, Regine R, Frongillo A, Nasti G, Maglione F. Morelli Coppola G, et al. Radiol Med. 2001 Nov-Dec;102(5-6):412-5. Radiol Med. 2001. PMID: 11779996 Italian. No abstract available.
• Transcatheter regional urokinase therapy in the management of inferior vena cava thrombosis.

  Angle JF, Matsumoto AH, Al Shammari M, Hagspiel KD, Spinosa DJ, Humphries JE. Angle JF, et al. J Vasc Interv Radiol. 1998 Nov-Dec;9(6):917-25. doi: 10.1016/s1051-0443(98)70422-1. J Vasc Interv Radiol. 1998. PMID: 9840035
• Deep cerebral venous thrombosis.

  Huh PW, Cho KS, Yoo DS, Kim JK, Kim DS, Kang JK. Huh PW, et al. Acta Neurochir (Wien). 2002 Jan;144(1):103-4; discussion 104-5. doi: 10.1007/s701-002-8280-x. Acta Neurochir (Wien). 2002. PMID: 11807653 No abstract available.
• Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.

  Collen D. Collen D. Prog Hemost Thromb. 1986;8:1-18. Prog Hemost Thromb. 1986. PMID: 3104986 Review. No abstract available.